Charles W Newhall III insider trades

Open-market stock purchases and sales by Charles W Newhall III, Director at Supernus Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 20, 2010.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +154%.

Recent trades

DateStockTradeValue
Feb 24, 2026SUPN Supernus Pharmaceuticals, IncBought (not open market)—
Feb 24, 2026SUPN Supernus Pharmaceuticals, IncSold (not open market)—
Feb 18, 2026SUPN Supernus Pharmaceuticals, IncBought (not open market)—
Feb 18, 2026SUPN Supernus Pharmaceuticals, IncBought (not open market)—
Nov 21, 2025SUPN Supernus Pharmaceuticals, IncBought (not open market)—
Oct 9, 2025SUPN Supernus Pharmaceuticals, IncSold$1.2M
Oct 9, 2025SUPN Supernus Pharmaceuticals, IncSold$61.9K

Companies traded

  • SUPN Supernus Pharmaceuticals, Inc: 1 buy, 7 sales, last Feb 24, 2026
  • VTAE Vitae Pharmaceuticals, Inc: other filings, last Jul 1, 2015
  • WDAY Workday, Inc: other filings, last Oct 17, 2012
  • FIO Fusion-Io, Inc: 2 sales, last Sep 4, 2012
  • HPTX Hyperion Therapeutics Inc: 1 buy, last Jul 31, 2012
  • PARS Pharmos Corp: other filings, last Jul 2, 2012
  • INWK Innerworkings Inc: 4 sales, last Mar 28, 2012
  • FOLD Amicus Therapeutics Inc: 2 buys, last Mar 7, 2012
  • ECHO Echo Global Logistics, Inc: other filings, last Feb 28, 2012
  • INHX Inhibitex, Inc: other filings, last Feb 13, 2012
  • VG Vonage Holdings Corp: other filings, last Mar 11, 2011
  • FNGN Financial Engines, Inc: other filings, last Aug 30, 2010

Get free alerts when Charles W Newhall III files a new trade →